
#604: How To Interpret Nutrition Research – David Allison, PhD
May 5, 2026 - 52:16
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized...
#596: Why Do Omega-3 Trials Show Mixed Results? is an episode from Sigma Nutrition Radio by Danny Lennon. Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial li...
This episode belongs to Sigma Nutrition Radio.
Use the player on this page to stream the episode online.
Published Mar 3, 2026, 01:06:11 long, audio available.
Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized trials show clear benefit while others show null or mixed findings, and how differences in trial design, dose, population risk, and outcome selection can materially change what we observe. A key theme is separating (1) the persistent cultural narratives around omega-3s (including origin stories that do not hold up well to modern evidence) from (2) the more precise, mechanistic and clinical questions about where supplemental EPA/DHA may reduce cardiovascular risk. The discussion focuses heavily on understanding heterogeneity: why "omega-3 supplementation" is not a single, uniform exposure, and why subgroup patterns (e.g., secondary prevention, higher baseline triglycerides, and higher doses) may explain much of the apparent conflict in the evidence. Note: This discussion is taken from a previous episode of the podcast. The audio has been remastered and improved, and now study notes and full transcript are available. Timestamps [04:10] Omega-3 historical context and Inuit studies [08:38] Mechanisms of omega-3 benefits [12:49] VITAL and ASCEND trials analysis [23:41] GISSI-Prevenzione trial insights [26:44] REDUCE-IT trial and residual risk [32:19] Significance of baseline triglycerides [37:57] 2018 Cochrane review [46:02] Hu et al. meta-analysis [01:00:27] Practical takeaways for omega-3 supplementation [01:03:55] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free
You can listen to #596: Why Do Omega-3 Trials Show Mixed Results? online on Radio and Podcast. Open the player on this page to stream the available audio.
#596: Why Do Omega-3 Trials Show Mixed Results? is an episode from Sigma Nutrition Radio by Danny Lennon.
This episode is 01:06:11 long.
This episode was published on Mar 3, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Sigma Nutrition Radio when more episodes are available from the podcast feed.
You can listen to #596: Why Do Omega-3 Trials Show Mixed Results? on this page when the episode audio is available from the podcast feed.
#596: Why Do Omega-3 Trials Show Mixed Results? is from Sigma Nutrition Radio by Danny Lennon.
Published Mar 3, 2026 and 01:06:11 long